Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (951-960 of 2,791) with videos related to

Pageof 280
Sort By:
Cytotherapy|January 19, 2008
Multicenter study on in vitro characterization of dendritic cellsH Eichler, X D Nguyen, D Roelen, et al.
Cytotherapy|January 19, 2008
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristicsD Campioni, F Lanza, S Moretti, et al.
Cytotherapy|January 19, 2008
Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis productsE Braakman, G J Schuurhuis, F W M B Preijers, et al.
Cytotherapy|January 19, 2008
Biocompatibility and membrane strength of C3H10T1/2 cell-loaded alginate-based microcapsulesW-J Zhang, B-G Li, C Zhang, et al.
Cytotherapy|September 6, 2007
MSC-DC interactions: MSC inhibit maturation and migration of BM-derived DCY-J Jung, S-Y Ju, E-S Yoo, et al.
Cytotherapy|September 6, 2007
Development of standardized cell culture conditions for tumor cells with potential clinical applicationG Stadler, M Wieser, F Steindl, et al.
Cytotherapy|October 6, 2007
Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioningL Chang, W C Chang, G McNamara, et al.
Cytotherapy|October 6, 2007
UC blood-derived mesenchymal stromal cells: an overviewA Flynn, F Barry, T O'Brien
Cytotherapy|October 20, 2006
Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humansK S Peggs
Cytotherapy|October 20, 2006
Ex vivo expansion of mafosfamide-purged PBPC productsI McNiece, C Civin, J Harrington, et al.
Pageof 280

Showing results (951-960 of 2,791) with videos related to

Sort By:
Pageof 280
Cytotherapy|January 19, 2008
Multicenter study on in vitro characterization of dendritic cellsH Eichler, X D Nguyen, D Roelen, et al.
Cytotherapy|January 19, 2008
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristicsD Campioni, F Lanza, S Moretti, et al.
Cytotherapy|January 19, 2008
Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis productsE Braakman, G J Schuurhuis, F W M B Preijers, et al.
Cytotherapy|January 19, 2008
Biocompatibility and membrane strength of C3H10T1/2 cell-loaded alginate-based microcapsulesW-J Zhang, B-G Li, C Zhang, et al.
Cytotherapy|September 6, 2007
MSC-DC interactions: MSC inhibit maturation and migration of BM-derived DCY-J Jung, S-Y Ju, E-S Yoo, et al.
Cytotherapy|September 6, 2007
Development of standardized cell culture conditions for tumor cells with potential clinical applicationG Stadler, M Wieser, F Steindl, et al.
Cytotherapy|October 6, 2007
Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioningL Chang, W C Chang, G McNamara, et al.
Cytotherapy|October 6, 2007
UC blood-derived mesenchymal stromal cells: an overviewA Flynn, F Barry, T O'Brien
Cytotherapy|October 20, 2006
Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humansK S Peggs
Cytotherapy|October 20, 2006
Ex vivo expansion of mafosfamide-purged PBPC productsI McNiece, C Civin, J Harrington, et al.
Pageof 280